ATE256134T1 - Sulfatierte phosphatidylinositole, ihre herstellung und verwendung - Google Patents
Sulfatierte phosphatidylinositole, ihre herstellung und verwendungInfo
- Publication number
- ATE256134T1 ATE256134T1 AT00903264T AT00903264T ATE256134T1 AT E256134 T1 ATE256134 T1 AT E256134T1 AT 00903264 T AT00903264 T AT 00903264T AT 00903264 T AT00903264 T AT 00903264T AT E256134 T1 ATE256134 T1 AT E256134T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfated
- pharmaceutical compositions
- phosphatidylinositols
- production
- sulfated phosphatidylinositol
- Prior art date
Links
- 150000003905 phosphatidylinositols Chemical class 0.000 title abstract 5
- 229940067626 phosphatidylinositols Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11616699P | 1999-01-15 | 1999-01-15 | |
| PCT/US2000/000749 WO2000042050A1 (en) | 1999-01-15 | 2000-01-12 | Sulfated phosphatidylinositols, their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE256134T1 true ATE256134T1 (de) | 2003-12-15 |
Family
ID=22365644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00903264T ATE256134T1 (de) | 1999-01-15 | 2000-01-12 | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6316424B1 (de) |
| EP (1) | EP1144420B1 (de) |
| JP (1) | JP2002534528A (de) |
| AT (1) | ATE256134T1 (de) |
| AU (1) | AU2503900A (de) |
| BR (1) | BR0007513A (de) |
| CA (1) | CA2356306C (de) |
| DE (1) | DE60007074T2 (de) |
| DK (1) | DK1144420T3 (de) |
| ES (1) | ES2214249T3 (de) |
| PT (1) | PT1144420E (de) |
| WO (1) | WO2000042050A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020065927A1 (en) | 2000-09-05 | 2002-05-30 | Janik Craig M. | Webpad and method for using the same |
| US20050084513A1 (en) * | 2003-10-21 | 2005-04-21 | Board Of Regents | Nanocoating for improving biocompatibility of medical implants |
| US20050239747A1 (en) * | 2004-04-21 | 2005-10-27 | Pharmaceutical Industry Technology And Development Center | Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods |
| TW200846031A (en) * | 2007-05-25 | 2008-12-01 | Shu-Yi Lin | Drug delivery system and the preparing method thereof |
| EP2231694A4 (de) * | 2007-12-18 | 2010-12-29 | Agency Science Tech & Res | Kationische kern-hülle-peptid-nanopartikel |
| US8715987B2 (en) * | 2011-05-02 | 2014-05-06 | New England Biolabs, Inc. | Solubilized phospholipids for stabilizing nucleic acid polymerases |
| CN108586574B (zh) * | 2018-04-26 | 2019-11-12 | 国家海洋局第三海洋研究所 | 氨基葡萄糖肽类化合物及其制备方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0293826A3 (de) * | 1987-06-02 | 1989-05-10 | Stichting REGA V.Z.W. | Therapeutische und prophylaktische Gabe von sulfatierten Polysacchariden gegen AIDS |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| US6602861B1 (en) * | 1992-04-16 | 2003-08-05 | Research Corporation Technologies, Inc. | Acylated phospholipid drugs |
| CA2255070C (en) * | 1996-05-16 | 2006-08-15 | Nissin Food Products Co., Ltd. | Novel compounds having antiviral activity |
-
2000
- 2000-01-12 BR BR0007513-2A patent/BR0007513A/pt not_active IP Right Cessation
- 2000-01-12 ES ES00903264T patent/ES2214249T3/es not_active Expired - Lifetime
- 2000-01-12 DK DK00903264T patent/DK1144420T3/da active
- 2000-01-12 PT PT00903264T patent/PT1144420E/pt unknown
- 2000-01-12 AU AU25039/00A patent/AU2503900A/en not_active Abandoned
- 2000-01-12 WO PCT/US2000/000749 patent/WO2000042050A1/en active IP Right Grant
- 2000-01-12 JP JP2000593617A patent/JP2002534528A/ja active Pending
- 2000-01-12 EP EP00903264A patent/EP1144420B1/de not_active Expired - Lifetime
- 2000-01-12 DE DE60007074T patent/DE60007074T2/de not_active Expired - Fee Related
- 2000-01-12 AT AT00903264T patent/ATE256134T1/de not_active IP Right Cessation
- 2000-01-12 CA CA002356306A patent/CA2356306C/en not_active Expired - Fee Related
- 2000-01-14 US US09/483,150 patent/US6316424B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000042050A1 (en) | 2000-07-20 |
| CA2356306C (en) | 2006-02-21 |
| CA2356306A1 (en) | 2000-07-20 |
| ES2214249T3 (es) | 2004-09-16 |
| JP2002534528A (ja) | 2002-10-15 |
| PT1144420E (pt) | 2004-04-30 |
| BR0007513A (pt) | 2001-11-20 |
| DE60007074T2 (de) | 2004-09-16 |
| EP1144420A1 (de) | 2001-10-17 |
| DK1144420T3 (da) | 2004-04-13 |
| EP1144420B1 (de) | 2003-12-10 |
| AU2503900A (en) | 2000-08-01 |
| US6316424B1 (en) | 2001-11-13 |
| DE60007074D1 (de) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE235895T1 (de) | Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis | |
| HUP0101293A2 (hu) | AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása | |
| NO953278L (no) | Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette | |
| IS1694B (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| ATE401892T1 (de) | Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand | |
| TR200102314T2 (tr) | Damar gelişimi inhibitörleri olarak kuinazolin türevleri. | |
| NO962088L (no) | Preparat for in vivo-produksjon av terapeutiske produkter | |
| DE69940674D1 (de) | Orale verabreichung von adenosin analogen | |
| NZ501950A (en) | Medicinal compositions for application to mucosa | |
| DK0781281T3 (da) | Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel | |
| NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
| DE3783356D1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| ATE353009T1 (de) | Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen | |
| ATE292453T1 (de) | Antivirale arznei | |
| TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
| IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
| ATE256134T1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung | |
| EA200200914A1 (ru) | Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина | |
| BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
| DE59708495D1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar | |
| ATE347886T1 (de) | Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen | |
| DE69803670D1 (de) | Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung | |
| DK1231908T3 (da) | Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1144420 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |